Clal Biotechnology Industries Ltd. (TLV:CBI)
Israel flag Israel · Delayed Price · Currency is ILS · Price in ILA
30.90
+0.70 (2.32%)
At close: Jan 30, 2026

TLV:CBI Ratios and Metrics

Millions ILS. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Jan '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
48556298185319
Market Cap Growth
-8.31%-12.09%-36.78%-46.87%-41.79%51.02%
Enterprise Value
7491109144336496
Last Close Price
0.310.350.400.631.181.75
PE Ratio
-----2.92
PS Ratio
--598.73266.21827.641546.13
PB Ratio
1.491.190.510.680.550.62
P/TBV Ratio
2.031.490.630.78-4.88
EV/Sales Ratio
--1046.55389.641498.602405.76
EV/EBITDA Ratio
---28.0634.0337.47
Debt / Equity Ratio
0.570.450.300.250.160.10
Debt / EBITDA Ratio
---7.155.453.84
Asset Turnover
--0.000.0000
Quick Ratio
0.120.252.014.651.706.95
Current Ratio
0.120.292.215.712.187.47
Return on Equity (ROE)
-79.13%-89.60%-21.10%-16.98%-15.63%25.13%
Return on Assets (ROA)
-4.33%-3.67%-3.73%-2.49%-1.49%-1.08%
Return on Capital Employed (ROCE)
-16.20%-13.90%-6.70%-7.00%-3.10%-1.80%
Earnings Yield
-65.09%-114.10%-49.87%-62.68%-48.32%34.23%
FCF Yield
--11.83%-13.68%-61.23%-23.15%-11.43%
Dividend Yield
-----12.54%
Buyback Yield / Dilution
12.84%-1.02%-1.01%1.74%-0.01%
Total Shareholder Return
12.84%-1.02%-1.01%1.74%12.53%
Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.